Sebana Medical is a pioneering brand at the forefront of innovation in the medical field. They specialize in the development, manufacturing, and commercialization of cutting-edge products using their breakthrough SEBA™ proprietary platform. Their flagship product, SEBA™, is a breakthrough technology that prevents fat resorption in fat grafting procedures, allowing for the long-lasting maintenance of grafted fat.

Specifically, SEBA™ is indicated for breast cancer survivor women undergoing breast reconstruction after a mastectomy. Sebana Medical aims to revolutionize the fat grafting technique by effectively preventing autologous fat reabsorption through their innovative drug delivery technology. They have successfully demonstrated the safety and efficacy of SEBA™ in rigorous preclinical studies, paving the way for its transition to clinical trials.

By harnessing the power of advanced drug slow-release polymer technology, Sebana Medical offers a transformative solution in soft tissue augmentation and various cosmetic indications. They are dedicated to advancing aesthetic medicine and transforming patient outcomes. Led by a team of experienced professionals in research, development, marketing, and regulatory affairs, Sebana Medical is committed to bringing SEBA™ to the forefront of aesthetic advancements.

With their upcoming clinical trials, they aim to provide a breakthrough innovation that holds immense potential for patients worldwide